Buscar
01/09/2024
Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery
Fa-Binefa, M, Rojas-Sayol, R, Peiró, A, Trullols, L, Machado, P, Gracia, I. Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery. JOURNAL OF ARTHROPLASTY. 2024; 39(9)DOI:10.1016/j.arth.2024.04.034. PMID:38640965. IF:3.800(Q1/2D).
01/09/2024
Reply to Maelle El Kefi, Philippe A. Liverneaux: Is ultrasound superior to fluoroscopy in distal radius volar fixation?
Toro-Aguilera, A, Arenas-Romera, J, Carrera, I, Lamas, C. Reply to Maelle El Kefi, Philippe A. Liverneaux: Is ultrasound superior to fluoroscopy in distal radius volar fixation?. Hand Surgery & Rehabilitation. 2024; 43(4)DOI:10.1016/j.hansur.2024.101763. PMID:39187066. IF:1.000(Q3/8D).
01/09/2024
Clavipectoral fascia plane block in midshaft clavicle fractures: A cadaveric study
Labandeyra, H, Heredia, C, Váldes-Vilches, LF, Prats-Galino, A, Sala-Blanch, X. Clavipectoral fascia plane block in midshaft clavicle fractures: A cadaveric study. JOURNAL OF CLINICAL ANESTHESIA. 2024; 96DOI:10.1016/j.jclinane.2024.111469. PMID:38678917. IF:5.100(Q1/1D).
01/09/2024
Cryobiopsy guided by electromagnetic navigation bronchoscopy for the diagnosis of peripheral lung nodules
Rafecas-Codern, A, Otero, AP, Colom, MN, Castosa, MV, Mitja, PS, Fernadez, AT, Ruiz, VP. Cryobiopsy guided by electromagnetic navigation bronchoscopy for the diagnosis of peripheral lung nodules. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1628. PMID:. IF:21.000(Q1/1D).
01/09/2024
Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis
Garc a-Alija, A, Park, HS, Moya, P, Laiz, A, Marco, C, Casals, A, Pitarch, C, Diaz-Torn , C, Magallares, BP, Barranco, IC, Fern ndez-S nchez, S, Garc a-Guillen, A, Tandaipan, JL, Codes-Mendez, H, Verdaguer, G, Sainz, L, Corominas, H. Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Electromagnetic navigation bronchoscopy-guided transbronchial dye marking for localization of peripheral lung lesions.
Otero, AP, Rafecas-Codern, A, Reyes, JCT, Tellez, EM, Mitja, PS, Brenes, JM, Nino, CAL, Canovas, GP, Colom, MN, Castosa, MV, Fernandez, AT. Electromagnetic navigation bronchoscopy-guided transbronchial dye marking for localization of peripheral lung lesions.. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1623. PMID:. IF:21.000(Q1/1D).
01/09/2024
Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis
Ballester-Servera, C, Alonso, J, Taurón, M, Rotllán, N, Rodríguez, C, Martínez-González, J. Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis. Clinica E Investigacion En Arteriosclerosis. 2024; 36(5)DOI:10.1016/j.arteri.2024.01.003. PMID:38402026. IF:(Q/D).
01/09/2024
Estimating the Glomerular Filtration Rate in the Pediatric Intensive Care Unit: using the Kinetic equation
Devolder, A, Resa, JC, Casals, JT, Fernandez, EC, Martínez, MR, Gomez, FC, Compañó, AP, Sanagustín, SB, Boronat, S, Rodriguez, GMF. Estimating the Glomerular Filtration Rate in the Pediatric Intensive Care Unit: using the Kinetic equation. PEDIATRIC NEPHROLOGY. 2024; 39(1)DOI:. PMID:. IF:2.600(Q1/2D).
01/09/2024
Design and Interrater Reliability of the Pediatric Version of the Race Scale: PedRACE
Turón-Viñas, E, Boronat, S, Gich, I, Alvarez, VG, García-Puig, M, Carreras, MC, Rodriguez-Palmero, A, Felipe-Rucián, A, Aznar-Laín, G, Jiménez-Fàbrega, X, de la Ossa, NP. Design and Interrater Reliability of the Pediatric Version of the Race Scale: PedRACE. STROKE. 2024; 55(9)DOI:10.1161/STROKEAHA.124.046846. PMID:39051112. IF:8.900(Q1/1D).
01/09/2024
A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE)
Giorgi, S, Auvin, S, Schoonjans, AS, Turón, E, Sánchez-Miranda, I, Gil-Nagel, A, Lagae, L, Aibar, JA. A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE). EPILEPSY & BEHAVIOR. 2024; 158DOI:10.1016/j.yebeh.2024.109958. PMID:39067307. IF:2.300(Q2/4D).
01/09/2024
Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy
Zangana, L, Valls, A, Munuera, J, Werner, M, Remollo, S, Dorado, L, Serena, J, Puig, J, de la Ossa, NP, Gomis, M, Bustamante, A, Pina, BF, Martinez, M, Castaño, C, Muñoz, L, Massuet, A, Coutinho, JM, Millán, M, Hernández-Pérez, M. Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy. Journal of Stroke. 2024; 26(3)DOI:10.5853/jos.2024.00150. PMID:39223974. IF:8.600(Q1/1D).
01/09/2024
Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels
Ferre-Giraldo, A, Castells, M, Sánchez-Herrero, JF, López-Rodrigo, O, de Rocco-Ponce, M, Bassas, L, Vigués, F, Sumoy, L, Larriba, S. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(18)DOI:10.3390/ijms251810122. PMID:39337607. IF:4.900(Q1/3D).
01/09/2024
Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease
Ben-Aicha, S, Anwar, M, Vilahur, G, Martino, F, Kyriazis, PG, de Winter, N, Punjabi, PP, Angelini, GD, Sattler, S, Emanueli, C. Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease. Jacc-Basic To Translational Science. 2024; 9(9)DOI:10.1016/j.jacbts.2024.05.003. PMID:39444932. IF:7.200(Q1/2D).
01/09/2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
de Isla, LP, Vallejo-Vaz, AJ, Watts, GF, Muñiz-Grijalvo, O, Alonso, R, Diaz-Diaz, JL, Arroyo-Olivares, R, Aguado, R, Argueso, R, Mauri, M, Romero, MJ, Alvarez-Baños, P, Mañas, D, Cepeda, JM, Gonzalez-Bustos, P, Casañas, M, Michan, A, Muñoz-Torrero, JFS, Faedo, C, Barba, MA, Dieguez, M, de Andrés, R, Hernandez, AM, Gonzalez-Estrada, A, Padró, T, Fuentes, F, Badimon, L, Mata, P. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study. Lancet Diabetes & Endocrinology. 2024; 12(9)DOI:10.1016/S2213-8587(24)00192-X. PMID:39098315. IF:41.800(Q1/1D).
01/09/2024
Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis
Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).
01/09/2024
Serum calprotectin in severe and mild COVID-19 patients
Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).
01/09/2024
Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period
Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).
01/09/2024
Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation
Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study
Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects
Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).
01/09/2024
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024)
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Hualpa, JCP, Garcia-Centeno, R, Gonzalez-Fernandez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Venegas, E, Gonzalez-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Cordova, JM, Aviles-Perez, MD, Asensio-Wandosell, D, Sampedro-Nunez, M, Camara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024). ENDOCRINE-RELATED CANCER. 2024; 31(9)DOI:10.1530/ERC-24-0043e. PMID:. IF:4.600(Q1/3D).
01/09/2024
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).
01/09/2024
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors
Ollivier-Hourmand, I, Lebedel, L, Alabau, BB, Goria, O, Bureau, C, Dumortier, J, Heurgue, A, Silvain, C, De-Ledinghen, V, Rautou, PE, Payance, A, Ballester, TG, Alvarado-Tapias, E, Hernandez-Gea, V, Valla, D, Zekrini, K, Nguyen, TTN, Dao, T, Pagan, JCG, Morello, R, Plessier, A. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. JOURNAL OF HEPATOLOGY. 2024; 81(3)DOI:10.1016/j.jhep.2024.04.016. PMID:38679069. IF:33.000(Q1/1D).
01/09/2024
Ultrasound in Rheumatology, It is a Must
Corominas, H, Badlissi, F. Ultrasound in Rheumatology, It is a Must. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.250324. PMID:39308354. IF:(Q/D).
01/09/2024
Ultrasound for the Diagnosis of Giant Cell Arteritis
Alarcón, PVE, Alvarado, PM, Alierta, ELS. Ultrasound for the Diagnosis of Giant Cell Arteritis. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.20104. PMID:39311386. IF:(Q/D).
01/09/2024
SSc-PAH patients are at risk of disease progression in contemporary clinical practice
Bjorkekjær, HJ, Bruni, C, Brunborg, C, Carreira, P, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Fretheim, H, Bitter, H, Midtvedt, O, Broch, K, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Müller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. SSc-PAH patients are at risk of disease progression in contemporary clinical practice. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2493. PMID:. IF:21.000(Q1/1D).
01/09/2024
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, E, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moya, P, Tortosa-Caba as, M, Navarro, VA, Calvet, J, Casafont-Sol , I, Rom n-Ivorra, JA, Labrada-Arrabal, S, Rocha, MV, I iguez, CL, Hern ndez-Hern ndez, V, Campos-Fern ndez, C, Villar, MA, Juan-Mas, A, Prado-Galbarro, FJ, Calvo, I, S nchez-Mart n, J, Narvaez-Garc a, J, Blanco-Alonso, R. ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study
Narvaez-Garc a, J, Llobell, A, Ponce, A, Gomez-Centeno, A, Mill n, AM, Corominas, H, Nolla, JM, Gomez-Puerta, JA. Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics
Carri n-Barber , I, Monte, TCS, Triginer, L, Garc a-Villanueva, M, Corral, SG, Frutos, AR, Font, J, Galindo-Izquierdo, M, Polo, CDF, Gil, JJF, Moriano, C, Alvarez, ED, Bernab u, P, Vela-Casasempere, P, Cortes-Hern ndez, J, Moreno, SS, Narvaez-Garc a, J, Hern ndez-Mart n, A, Magallares, BP, Garc a, MP, Marras, C, Ramos, C, Gomez-Puerta, JA, Frade-Sosa, B, Fern ndez-Ortiz, A, Garcia-Aparicio, A, Altab s-Gonz lez, I, Hern ndez-Baldiz n, S, Ros-Vilamajo, I, Cirera, SG, Bufort, MG, Sala, L, Mart nez-Barrio, J, de Salazar, JRG, Heredia, S, Torrente-Segarra, V, Brandy-Garcia, AM, Del Amo, NDV, Fito-Manteca, C, Calvo-Alen, J, Pego-Reigosa, JM, R a-Figueroa, I. Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry
Narvaez-Garc a, J, Dominguez-Alvaro, M, Gal ndez-Agirregoikoa, E, Mendizabal, J, Alcazar, IA, Loricera, J, Garrido-Pu al, N, Casta eda, S, Moya, P, Larena, C, Estrada-Alarc n, P, Galisteo, C, Frutos, AR, Sanjuan, FO, Monte, TCS, Rocha, MV, Ubiaga, CLI, Garcia-Gonzalez, M, Blanco-Alonso, R. Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry
Fern ndez-Lozano, D, Dom nguez-Alvaro, M, Narvaez-Garc a, J, Garrido-Pu al, N, De Miguel, E, Estrada-Alarc n, P, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, S nchez-Mart n, J, Calvo, I, Aldasoro, V, Alcazar, LA, Loricera, J, Moya, P, Garc a-Villanueva, M, S nchez-Alonso, F, Casta eda, S, Hern ndez, JL, Blanco-Alonso, R. Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment
G mez, MLI, Escudero, PG, L pez, BM, Dorta, AG, Frade-Sosa, B, Lizarzaburu, MS, R a-Figueroa, I, Su rez, DVF, de Miera, FJTS, Melero-Gonzalez, RB, Santos, DD, Miranda, JA, Belando, CG, Boselli, G, Boteanu, AL, Selaya, CC, Santos, CS, Alvarez, ED, Font, J, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, G mez, IV, Vela-Casasempere, P, Merino, C, Mart nez, MI, Beriain, JAH, Roman, AMR, Calvo-Al n, J. Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study
Mysler, E, Ignatenko, S, Gordienko, A, Cort s-Hern ndez, J, Agmon-Levin, N, Narongroeknawin, P, Romanowska-Prochnicka, K, Shen, N, Cifersk , H, Kodera, M, Wei, JCC, Leszczynski, P, Lan, JL, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Dai, L, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, Magallares, BP, Sengupta, T, Sips, C, Lau, C, Avrameas, A, Oliver, SJ. Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease
Zhang, YL, Tedeschi, S, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, J, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, D az, C, McCarthy, G, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Tarancon, LC, Stamp, L, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, FitzGerald, J, Dalbeth, N. Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Effectiveness of Rituximab in IgG4 Related Disease
Lopez-Gutierrez, F, Loricera, J, Hormigos, C, Nu ez, DF, Rodriguez-Laguna, M, Albarado, PM, G mez, MLI, Corominas, H, Silva-D az, M, Arribas, GG, Garcia-Aparicio, A, Urgelles, JF, Casafont-Sole, I, Calabuig, PM, Castaneda, E, Merino, C, Zas, R, Molina-Collada, J, Melero-Gonzalez, RB, Galindez-Agirregoikoa, E, Hern ndez-Mart n, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, V zquez, NM, Gallego-Flores, A, Ra a, NC, Veroz, R, Andres, M, Casta eda, S, Blanco-Alonso, R. Effectiveness of Rituximab in IgG4 Related Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis
Guerrero, MR, Moriano, C, Santos, CS, Herranz, LS, Garcia, JJ, Barranco, IC, Alvarez, ED. Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study
De Silva, C, D az, C, Gamble, G, Horne, A, Doyle, A, Stamp, L, Dalbeth, N. Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases
Quevedo-Rodr guez, A, Otero-Varela, L, S nchez-Alonso, F, P rez-Vera, Y, Manero-Ruiz, J, Campos-Fern ndez, C, Manrique-Arija, S, Vela-Casasempere, P, Mera-Varela, A, D az, C, Movasat, A, Garcia-Magallon, B, Ros-Vilamaj , I, Perez-Garcia, C, Castrejon, I. Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).
01/09/2024
Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort
D'Alessandro, R, Rodolfi, S, Calot, A, Bebear, L, Campochiaro, C, Codullo, V, Del Galdo, F, Barranco, IC, Zanatta, E, Randone, SB, Boleto, G, Raffray, L, Chatelus, E, Cacoub, P, Le Joncour, A, Airo, P, Santos, CS, Lescoat, A, Avouac, J, Denton, C, Allanore, Y. Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).